Activity of Ro 236240, Ro 158074 and Ro 195247 against resistant gonococci.
Easmon
C S
CS
Department of Medical Microbiology, Wright-Fleming Institute, St. Mary's Hospital Medical School, London, England.
Woodford
N
N
Ison
C A
CA
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D015281:Cefmenoxime / Q000031:analogs & derivatives* / Q000494:pharmacology; D015296:Ceftizoxime / Q000031:analogs & derivatives* / Q000494:pharmacology; D002939:Ciprofloxacin / Q000031:analogs & derivatives* / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D016576:Fleroxacin; D006801:Humans; D008826:Microbial Sensitivity Tests; D009344:Neisseria gonorrhoeae / Q000187:drug effects* / Q000302:isolation & purification
D000900:Anti-Bacterial Agents; C047444:cefetamet; D002939:Ciprofloxacin; C049493:cefteram; D015296:Ceftizoxime; D015281:Cefmenoxime; D016576:Fleroxacin